Abstract:Background: Esophageal squamous cell carcinoma (ESCC), a prevalent malignancy within the upper gastrointestinal system, is characterized by its unfavorable prognosis and the absence of specific indicators for outcome prediction and high-risk case identification. In our research, we examined the expression levels of cancer stem cells (CSCs), markers CD44/SOX2 in ESCC, scrutinized their association with clinicopathological parameters, and developed a predictive nomogram model. This model, which incorporates CD44/SOX2, aims to forecast the overall survival (OS) of patients afflicted with ESCC. Methods: Immunohistochemistry was utilized to detect the expression levels of CD44 and SOX2 in both cancerous and paracancerous tissues of 68 patients with ESCC. The correlation between CD44/SOX2 expression and clinicopathological parameters was subsequently analyzed. Factors impacting the prognosis of ESCC patients were assessed through univariate and multivariate Cox regression analyses. Leveraging the results of these multivariate regression analyses, a nomogram prognostic model was established to provide individualized predictions of ESCC patient survival outcomes. The predictive accuracy of the nomogram prognostic model was evaluated using the consistency index (C-index) and calibration curves. Results: The expression levels of CD44 were markedly elevated in the tumor tissues of ESCC patients. Similarly, SOX2 was significantly overexpressed in the tumor tissues of ESCC patients. The positive expression of SOX2 in ESCC demonstrated a strong correlation with both the pathological T-stage and the presence of carcinoembryonic antigen. CD44 and SOX2 co-positive expression was significantly associated with the pathological T-stage and tumor node metastasis (TNM) stage. Furthermore, ESCC patients exhibiting CD44-positive expression in their tumor tissue generally had a more adverse prognosis. The co-expression of CD44 and SOX2 resulted in a grimmer prognosis compared to patients with other combinations. Multivariate Cox regression analysis identified the co-expression of CD44 and SOX2, the pathological T-stage, and lymph node metastasis as independent prognostic indicators for ESCC patients. The three identified variables were subsequently incorporated into a nomogram for predicting OS. The C-index of the measurement model and the area under the curve of the subjects' work characteristics showed good individual prediction. This prognostic model stratified patients into low- and high-risk categories. Analysis revealed that the 5-year OS rate was significantly higher in the low-risk group compared to the high-risk group. Conclusions: Elevated CD44 levels, indicative of CSC presence, are intimately linked with the oncogenesis of ESCC and are strongly predictive of unfavorable patient outcomes. Concurrently, the SOX2 gene exhibits a heightened expression in ESCC, markedly accelerating tumor progression and fostering more extensive disease infiltration. The co-expression of CD44 and SOX2 correlates significantly with ESCC patient prognosis, serving as a reliable, independent prognostic marker. Our constructed nomogram, incorporating CD44/SOX2 expression, enhances the prediction of OS and facilitates risk stratification in ESCC patients.

The relationship between cyclooxygenase-2, CD44v6, and nm23H1 in esophageal squamous cell carcinoma.

Expression of P53, P16 and Cyclooxygenase-2 in Esophageal Cancer with Tissue Microarray

Relationship between COX-2 and cell cycle-regulatory proteins in patients with esophageal squamous cell carcinoma.

Relationship between the expressions of hypoxia inducible factor 1-α and cyclooxygenase-2 and the biological behavior in esophageal squamous carcinoma

Expression and Significance of COX-2 and VEGF in Esophageal Squamous Cell Carcinoma

Significance of Cox-2 Expression in Human Esophageal Squamous Cell Carcinoma

Prevalence of Gene Amplifications of Sox-2, C-Met, and Fgfr1 in Asian Patients with Esophageal Squamous Cell Carcinoma.

Pathway Analysis of Differentially Expressed Genes in Human Esophageal Squamous Cell Carcinoma.

Expression and Association of CD44v6 with Prognosis in T2-3N0M0 Esophageal Squamous Cell Carcinoma.

Cyclooxygenase-2 is over-expressed in Chinese esophageal squamous cell carcinoma, and correlated with NF-κB: An immunohistochemical study

Clinicopathological significance of cancer stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma (ESCC) patients and construction of a nomogram to predict overall survival

Expression of CD44v6 and E-cadherin in esophageal squamous cell carcinoma and its clinical significance

Expression of CD44 and nm23 gene protein in esophageal cancer

Clinicopathological Significance of Cyclooxygenase-2 and Cell Cycle-Regulatory Proteins Expression in Patients with Esophageal Squamous Cell Carcinoma.

The Relationship Between Hpv16 and Expression of Cyclooxygenase-2, P53 and Their Prognostic Roles in Esophageal Squamous Cell Carcinoma

Evaluation of the Correlativity of Gender Determining Region Y-box 4, N-cadherin, CD44 and E-cadherin Expression in the Prognosis of Esophageal Squamous Cell Carcinoma.

CD44 Protein and P-gp in the Carcinoma Tissue of Squamous Esophageal Mucosa

Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus.

Effects of Cyclooxygenase-2 on Human Esophageal Squamous Cell Carcinoma.

The Expression of CXCR4 and Its Relationship with Matrix Metalloproteinase-9/Vascular Endothelial Growth Factor in Esophageal Squamous Cell Cancer

Overexpression of Phospholipase A2 Group IIA in Esophageal Squamous Cell Carcinoma and Association with Cyclooxygenase-2 Expression.